SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunex
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
656 41 0 IMNX
Emcee:  Michael Yang Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
631From an IMNX investor standpoint I'm not real happy with the deal, either. John Curtis-12/17/2001
630I hate the deal. $30, assuming Amgen doesn't continue to fall. IMNX is givLemurHouse-12/17/2001
629Here's just about the most cogent explanation I've yet read regarding thJohn Curtis-12/14/2001
628AHP is cash beneficiary, Imnx ends misery, Amgen buys time! 1. AHP gets most ofCacaito-12/14/2001
627IMNX is unlikely to see $30 anytime soon if AMGN continues to sell-off. With theMike K-12/14/2001
626<i>Deal or no deal, IMNX is still attractive at 26-28 with a price target John Curtis-12/14/2001
625Deal or no deal, IMNX is still attractive at 26-28 with a price target of 30 by eric ross-12/14/2001
624AHP maybe committed but IMHO not to 32-35 range. AHP and IMNX have enough resoureric ross-12/14/2001
623Amgen is down over 12% in the last 2 days. The market doesn't like this dealMike K-12/14/2001
622WSJ reporting today's edition a $31-32 acquisition price. Some AMGN supportquidditch-12/14/2001
621By the way...let's not forget AHP who's in a position to acquire IMNX. Ieric ross-12/13/2001
620Hi John.... I am sure that AMGEN has taken into consideration all the assets of eric ross-12/13/2001
619I'm wondering how AMGN looks at the value of the buildings in process by IMJohn O'Neill-12/13/2001
618<i>As an IMNX shareholder I'm not at all happy about this. I think IMNJohn Curtis-12/13/2001
617Now we are talking. IMHO, Immunex nor AHP will not settle for anything less thaneric ross-12/13/2001
616I guess I spoke too soon. Faber on CNBC is reporting on it right now. Price saLemurHouse-12/13/2001
615I read that too, with Amgen being the potential acquirer. I don't see it haLemurHouse-12/13/2001
61410:44 ET Rumor Mill : Immunex (IMNX 26.24 +1.79, +7%) is a stand out today in a michael97123-12/13/2001
613I know that I missed the run because my bid was about 30 cents off yesterday'TimF-12/13/2001
612anyone know about imnx 11% run today?michael97123-12/13/2001
611teevee either its a is a potent immunosuppressant or it aint if it is it givdalroi-12/9/2001
610Richard, Off topic: Isotechnika claims that its drug ISAtx247 is a potent immunoteevee-12/9/2001
609In some way, you have to thank UBS, etc. for giving us an opportunity to buy moreric ross-12/5/2001
608Eric & Andrew: <i>There was an analyst or some such on CNBC this mornJohn Curtis-12/3/2001
607Plain ignorance, or the inability to look farther than the current quarter are oLemurHouse-12/3/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News